Cancer groups say Trump administration’s drug pricing rule will likely harm patients December 04, 2020Vol.46 No.45By Paul Goldberg
NCI Sharpless: “This is one of the most uncertain budget environments that I think the NCI has ever experienced.” December 04, 2020Vol.46 No.45By Alexandria Carolan
Federate the data: NCI produces master plan for the Childhood Cancer Data Initiative December 04, 2020Vol.46 No.45By Matthew Bin Han Ong
FreeLetter To The Editor AACI: President-elect Biden has proven his unyielding commitment to defeating cancer November 20, 2020Vol.46 No.44
COVID-19 & CancerFree Cancer hospitals stay open as COVID-19 cases skyrocket November 20, 2020Vol.46 No.44By Alexandria Carolan
Conversation with The Cancer LetterFree ASCO’s new CMO Julie R. Gralow will focus on equity, advocacy, and global health November 20, 2020Vol.46 No.44By Paul Goldberg
FreeNews Analysis Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot November 16, 2020Vol.46 No.44By Matthew Bin Han Ong
Trials & Tribulations #BCSM: Breast cancer social media hashtag gives voice to a community November 13, 2020Vol.46 No.43By Deanna J. Attai and Matthew S. Katz
FreeObituary David A. Ahlquist, pioneer of cancer screening, dies at 69 November 13, 2020Vol.46 No.43
FreeNews Analysis Joe Biden has an unparalleled grasp of the science and politics of cancer November 13, 2020Vol.46 No.43By Matthew Bin Han Ong